| Antimicrobial peptides (AMPs): roles, functions and mechanism of action R Seyfi, FA Kahaki, T Ebrahimi, S Montazersaheb, S Eyvazi, ... International Journal of Peptide Research and Therapeutics 26, 1451-1463, 2020 | 144 | 2020 |
| Overview of CD24 as a new molecular marker in ovarian cancer V Tarhriz, M Bandehpour, S Dastmalchi, E Ouladsahebmadarek, ... Journal of cellular physiology 234 (3), 2134-2142, 2019 | 101 | 2019 |
| Antibody based EpCAM targeted therapy of cancer, review and update S Eyvazi, S Farajnia, S Dastmalchi, F Kanipour, H Zarredar, ... Current Cancer Drug Targets 18 (9), 857-868, 2018 | 92 | 2018 |
| MicroRNAs in breast cancer: Roles, functions, and mechanism of actions M Abolghasemi, SS Tehrani, T Yousefi, A Karimian, A Mahmoodpoor, ... Journal of cellular physiology 235 (6), 5008-5029, 2020 | 80 | 2020 |
| Recent advances on portable sensing and biosensing assays applied for detection of main chemical and biological pollutant agents in water samples: A critical review H Sohrabi, A Hemmati, MR Majidi, S Eyvazi, A Jahanban-Esfahlan, ... TrAC Trends in Analytical Chemistry 143, 116344, 2021 | 79 | 2021 |
| Epigenetic modifications in gastric cancer: Focus on DNA methylation V Ebrahimi, A Soleimanian, T Ebrahimi, R Azargun, P Yazdani, S Eyvazi, ... Gene 742, 144577, 2020 | 67 | 2020 |
| Involvement of CD24 in multiple cancer related pathways makes it an interesting new target for cancer therapy S Eyvazi, B Kazemi, S Dastmalchi, M Bandehpour Current cancer drug targets 18 (4), 328-336, 2018 | 54 | 2018 |
| Layered double hydroxide nanoparticles as an appealing nanoparticle in gene/plasmid and drug delivery system in C2C12 myoblast cells P Yazdani, E Mansouri, S Eyvazi, V Yousefi, H Kahroba, MS Hejazi, ... Artificial cells, nanomedicine, and biotechnology 47 (1), 436-442, 2019 | 52 | 2019 |
| The oncogenic roles of bacterial infections in development of cancer S Eyvazi, MA Vostakolaei, A Dilmaghani, O Borumandi, MS Hejazi, ... Microbial pathogenesis 141, 104019, 2020 | 47 | 2020 |
| Critical roles of long noncoding RNAs in breast cancer M Abolghasemi, SS Tehrani, T Yousefi, A Karimian, A Mahmoodpoor, ... Journal of cellular physiology 235 (6), 5059-5071, 2020 | 44 | 2020 |
| Recent advances on development of portable biosensors for monitoring of biological contaminants in foods S Eyvazi, B Baradaran, A Mokhtarzadeh, M de la Guardia Trends in Food Science & Technology 114, 712-721, 2021 | 42 | 2021 |
| State-of-the-art cancer biomarker detection by portable (Bio) sensing technology: A critical review H Sohrabi, N Bolandi, A Hemmati, S Eyvazi, S Ghasemzadeh, ... Microchemical Journal 177, 107248, 2022 | 41 | 2022 |
| Transient induction of Cdk9 in the early stage of differentiation is critical for myogenesis V Tarhriz, S Eyvazi, M Musavi, M Abasi, K Sharifi, H Ghanbarian, ... Journal of cellular biochemistry 120 (11), 18854-18861, 2019 | 40 | 2019 |
| An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages SZB Mahdavi, F Oroojalian, S Eyvazi, M Hejazi, B Baradaran, N Pouladi, ... International Journal of Biological Macromolecules 208, 421-442, 2022 | 39 | 2022 |
| Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis Y Aftabi, K Ansarin, D Shanehbandi, M Khalili, E Seyedrezazadeh, ... IUBMB life 73 (2), 307-327, 2021 | 37 | 2021 |
| Synthesis and application of magnetic@ layered double hydroxide as an anti-inflammatory drugs nanocarrier V Yousefi, V Tarhriz, S Eyvazi, A Dilmaghani Journal of Nanobiotechnology 18, 1-11, 2020 | 37 | 2020 |
| Immune therapy of melanoma: overview of therapeutic vaccines Z Payandeh, M Yarahmadi, Z Nariman‐Saleh‐Fam, V Tarhriz, M Islami, ... Journal of Cellular Physiology 234 (9), 14612-14621, 2019 | 37 | 2019 |
| Expression pattern of miR-21, miR-25 and PTEN in peripheral blood mononuclear cells of patients with significant or insignificant coronary stenosis SZ Vahed, SH Aghaee-Bakhtiari, A Daraei, Z Saadatian, HS Kafil, ... Gene 698, 170-178, 2019 | 37 | 2019 |
| Critical microRNAs in lung cancer: recent advances and potential applications H Zarredar, K Ansarin, B Baradaran, N Shekari, S Eyvazi, F Safari, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 36 | 2018 |
| CDK9 as an appealing target for therapeutic interventions S Eyvazi, MS Hejazi, H Kahroba, M Abasi, RE Zamiri, V Tarhriz Current Drug Targets 20 (4), 453-464, 2019 | 31 | 2019 |
Vahideh TarhrizLouisiana State University Health Sciences Center New Orleans, LA, USAAdresse e-mail validée de lsuhsc.edu
